Does RISANKIZUMAB Cause Crohn's disease? 103 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Crohn's disease have been filed in association with RISANKIZUMAB (Skyrizi). This represents 3.9% of all adverse event reports for RISANKIZUMAB.
103
Reports of Crohn's disease with RISANKIZUMAB
3.9%
of all RISANKIZUMAB reports
1
Deaths
23
Hospitalizations
How Dangerous Is Crohn's disease From RISANKIZUMAB?
Of the 103 reports, 1 (1.0%) resulted in death, 23 (22.3%) required hospitalization, and 3 (2.9%) were considered life-threatening.
Is Crohn's disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB Cause?
Product storage error (396)
Drug ineffective (206)
Psoriasis (138)
Arthralgia (100)
Off label use (100)
Product temperature excursion issue (88)
Diarrhoea (72)
Fatigue (70)
Rash (64)
Pruritus (61)
What Other Drugs Cause Crohn's disease?
ADALIMUMAB (15,916)
VEDOLIZUMAB (9,759)
INFLIXIMAB (7,777)
USTEKINUMAB (4,662)
METHOTREXATE (2,869)
CERTOLIZUMAB PEGOL (2,688)
PREDNISONE (1,518)
RISANKIZUMAB-RZAA (1,338)
AZATHIOPRINE (1,265)
MESALAMINE (1,235)
Which RISANKIZUMAB Alternatives Have Lower Crohn's disease Risk?
RISANKIZUMAB vs RISANKIZUMAB-RZAA
RISANKIZUMAB vs RISDIPLAM
RISANKIZUMAB vs RISEDRONATE
RISANKIZUMAB vs RISEDRONIC ACID
RISANKIZUMAB vs RISPERDAL